Back to
GLENMEDE TRUST CO NA
TGTX
Showing 0 of 6 quarters
Position history for
GLENMEDE TRUST CO NA's holdings in TG THERAPEUTICS INC
No. Glenmede Trust exited its TGTX (TG Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 15,562 shares worth $184,098. Glenmede Trust first reported TGTX in Q4 2020 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.